Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
If someone's always late, is it time blindness, or are they just being rude?- Turning into a Distributed Writer: My Composing Process
- 21 Things You Ought to Never Tell Your Childless Companion
- Ukraine to get up to 100 French-made Rafale fighter jets
- Mossad unveils network of Hamas terror infrastructure across Europe
- The most effective method to Pick the Right Material Organization: Your Definitive Aide
- Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
- My Excursion to a Better Way of life: Health Experiences
- Flourishing in Retirement: Individual Accounts of Post-Profession Satisfaction
